Print
Sex and intimacy after breast cancer
https://www.facingourrisk.org/XRAY/sex-and-intimacy-after-breast-cancer
Full article: https://www.frontiersin.org/articles/10.3389/fpsyg.2022.864893/full
A breast cancer diagnosis and treatment can affect relationships with romantic partners. This review highlights two studies that looked at how people with breast cancer and their partners are affected, how they cope, how best to communicate with each other and how to talk with healthcare providers about concerns related to cancer and sexuality. (Posted 8/8/23)
Este artículo está disponible en español.
Questions To Ask Your Health Care Provider
- What are the common sexual side effects of my treatment?
- What are some ways of coping with these effects?
- Can I include my partner in my appointments?
- Can you refer me to a sexual health expert?
- Where can I find more resources and information on this topic?
Open Clinical Trials
The following research studies related to sexual health are enrolling patients.
Multiple cancers
- NCT04806724: Opening the Conversation Study. This study will look at a program designed to help young couples who are dealing with breast or gynecologic cancer cope with and communicate about cancer-related reproductive and sexual health concerns.
- NCT04049331: Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone. The overall goal of this study is to evaluate the effect of a testosterone drug called Depo-Testosterone (testosterone cypionate), an FDA-approved drug for improving fatigue, sexual function, quality of life, body composition, muscle strength and physical activity in young cancer survivors who report fatigue and have low testosterone. This study is not open to men who have been diagnosed with hormone-related cancers, including prostate or breast cancer.
Breast cancer
Colorectal cancer
Prostate cancer
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.